2021
DOI: 10.1088/1752-7163/ac22bb
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19: the new cause of dyspnoea as a result of reduced lung and peripheral muscle performance

Abstract: This study aimed to evaluate the cardiopulmonary function and impairment of exercise endurance in patients with COVID-19 after 3 months of the second wave of the pandemic in Turkey. A total of 51 consecutive COVID-19 survivors, mostly healthcare providers, still working in the emergency room and intensive care units of the hospital after the second wave of Covid 19 pandemia were included in this study. Cardiopulmonary exercise stress test was performed. The median of the exercise time of the COVID-19 survivors… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
10
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 18 publications
0
10
1
Order By: Relevance
“…As discussed earlier on, O 2 /work rate ratio was abnormal at 3 months post-infection [ 44 ] and only slightly reduced or normal between 3 and 9 months post-infection (see Sect. 3.3 ) [ 6 , 32 , 34 , 43 ].…”
Section: Resultsmentioning
confidence: 61%
See 4 more Smart Citations
“…As discussed earlier on, O 2 /work rate ratio was abnormal at 3 months post-infection [ 44 ] and only slightly reduced or normal between 3 and 9 months post-infection (see Sect. 3.3 ) [ 6 , 32 , 34 , 43 ].…”
Section: Resultsmentioning
confidence: 61%
“…Spirometry parameters ⇔ ⇓ DLCO ⇓ (74% of pred.) Breathing reserve ⇔ ⇓ (< 25% in 11 patients) Decreased physical fitness ( N = 11, 35.5%) or decreased ventilatory capacity ( N = 5, 16%) as main reason for abnormal CPET Acar et al [ 44 ] N = 51 42 (NR) y, 55% male NR ex-/smoker = NR diabetes = NR Moderate ( n = 34), severe ( n = 17) Inclusion: patients who survived the second wave of the COVID-19 pandemic Exclusion: contraindications to CPET (i.e. unstable angina, arrhythmia, severe aortic stenosis, heart failure, pulmonary hyper-tension, atrioventricular blocks, or severe hypertension) Assessed at 3 months post-NR: O 2peak ⇓ (85% of pred.)…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations